Charles Marlowe, Phd Email & Phone Number

BayMedica's world class scientific team has developed an efficient and scalable yeast-based biosynthesis platform for cannabinoids. Their disruptive, patent-pending technology enables the manufacture of both naturally occurring and novel pharmaceutical-grade cannabinoids, with a lower cost than that of plant-derived cannabinoids. BayMedica is extremely well positioned to take advantage of the projected explosive pharmaceutical cannabinoid science market.

Offers consulting to startup and later stage biotechnology and pharmaceutical companies specializing in small molecule therapeutics: lead identification, validation, optimization, chemical design and synthesis, SAR analysis as well as therapeutic candidate identification/selection through review of ADME, PK and PD data, followed by process development, and technical transfer to competent CROs or internal groups. Expert opinion on intellectual property identification, structural landscape, and chemical patent preparation as well. Technical transfer of synthetic processes, management of Contract Research Organizations and pre-IND enabling documentation also supported.

Alameda, California, Us

Cambridge, Ma, Us

Emeryville, California, Us

Indianapolis, In, Us

Nih Postdoctoral Fellow, Organic Chemistry

Phd, Chemistry, Synthetic & Bioorganic

Bs/Bs, Chemistry/Biology